A biotech delegation led by Deputy Director-General Shu-Chu Chen of the Hsinchu Science Park Bureau, Ministry of Science and Technology, went to Tokyo for a business matching fair on Oct. 23, 2019 and signed a Memorandum of Understanding (MOU) with Japanese health care institution Social Welfare Corporation, Shiyuukai on Oct. 26, 2019, with the intent to extend businesses and market in Japan for biomedical manufacturers at the Hsinchu Science Park.
In dealing with a large aging population, the government and private sectors in Japan have accumulated professional experience in long-term care, establishing a benchmark model for other countries.
The Japanese health care institution “Social Welfare Corporation, Shiyuukai” has already established six business bases in cooperation with local governments by use of its rich experience in elderly care, offering a variety of services related to long-term care via utilization of high-end medical services and equipment such as robotic equipment, as well as digital platforms for monitoring physiological parameters and surgical rehabilitation, including the first successful case related to long-term care with ties between urban and rural areas in Japan.
Apart from technical aspects, clinical and market acceptance are also important considerations for medical device utilization.
Three medical device manufacturers from the Hsinchu Science Park, i.e. North-vision Technology, Brain Navi Biotechnology, and Advanced Biomedical Technology, signed a Memorandum of Understanding (MOU) with Social Welfare Corporation, Shiyuukai under the witness of Deputy Director-General Chen of the Hsinchu Science Park Bureau.
Shiyuukai’s product technology applications and clinical experiences gave manufacturers of Hsinchu Science Park a better perspective on the requirements of health care industries in Japan, helping to build up a platform for those who are interested in extending the Japanese health care market.
The bilateral ties between Japan and Taiwan in terms of technology and industry cooperation further promotes global visibility of biomedical manufacturers at the Hsinchu Science Park.
